logo-loader
Parity Group plc

Parity plunges as it issues profit warning amid large contract delay

The group said that despite progress in revenues, adjusted pre-tax profits would be around breakeven for the second half of the year

Profit decline
Parity also said it had begun a review of project profitability and staff utilisation

Shares in recruitment and tech consultancy Parity Group PLC (LON:PTY) plunged in late-afternoon trading Friday as it issued a profit warning for the full year after a delay in the extension of a large contract continued into the second half.

The group added that even if the contract was eventually approved, its scope would be “reduced” and despite progress in revenues, adjusted pre-tax profits would be around breakeven for the second half of the year.

READ: Parity shares gain as it expects double-digit growth in first-half profits

Considering the pressures on the business, the firm said it had initiated several actions including a review of project profitability and staff utilisation with cost reductions which would benefit 2019 as well as a restructuring of its Parity Consultancy Services (PCS) division to focus on “new Data consultancy opportunities”.

Parity also said it was re-prioritising its pipeline and relationship management process to “ensure appropriate engagement” on fewer but more likely and more profitable projects.

As a result of the initiatives, the company expected to incur around £300,000-£400,000 of non-recurring costs in restructuring the PCS division.

Shares were down 29.4% at 6.9p.

-- Adds share price --

Quick facts: Parity Group plc

Price: £0.07

Market: LSE
Market Cap: £7.44 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: CB2 Insights licenses electronic data capture software to UK...

CB2 Insights (CSE:CBII-OTCQB: CBIIF) CEO Prad Sekar joined Steve Darling from Proactive Vancouver to discuss the company doing a deal with MYACCESS Clinics. This will allow CB2’s software to capture comprehensive data sets related to patient health and treatment histories and manage ongoing...

8 hours, 9 minutes ago

RNS

Half-year Report

18 hours, 24 minutes ago

Holding(s) in Company

4 weeks, 2 days ago

Result of AGM

on 30/5/19

2 min read